SI1143997T1 - Tumor necrosis factor antagonists and their use in endometriosis treatment - Google Patents

Tumor necrosis factor antagonists and their use in endometriosis treatment

Info

Publication number
SI1143997T1
SI1143997T1 SI200030168T SI200030168T SI1143997T1 SI 1143997 T1 SI1143997 T1 SI 1143997T1 SI 200030168 T SI200030168 T SI 200030168T SI 200030168 T SI200030168 T SI 200030168T SI 1143997 T1 SI1143997 T1 SI 1143997T1
Authority
SI
Slovenia
Prior art keywords
necrosis factor
tumor necrosis
factor antagonists
endometriosis treatment
endometriosis
Prior art date
Application number
SI200030168T
Other languages
English (en)
Slovenian (sl)
Inventor
Francesco Borrelli
Mauro D'ANTONIO
Fabrizio Martelli
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1143997(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of SI1143997T1 publication Critical patent/SI1143997T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200030168T 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis treatment SI1143997T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99101194A EP1022027A1 (en) 1999-01-22 1999-01-22 Tumor necrosis factor antagonists and their use in endometriosis
EP00900306A EP1143997B1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis treatment
PCT/IB2000/000052 WO2000043031A1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis

Publications (1)

Publication Number Publication Date
SI1143997T1 true SI1143997T1 (en) 2003-12-31

Family

ID=8237393

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030168T SI1143997T1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis treatment

Country Status (30)

Country Link
US (2) US6663865B1 (ja)
EP (2) EP1022027A1 (ja)
JP (1) JP4601176B2 (ja)
KR (2) KR20060128056A (ja)
CN (2) CN1212152C (ja)
AR (1) AR022251A1 (ja)
AT (1) ATE242002T1 (ja)
AU (1) AU771964B2 (ja)
BG (1) BG65556B1 (ja)
BR (1) BR0008182A (ja)
CA (1) CA2356737C (ja)
CZ (1) CZ302866B6 (ja)
DE (1) DE60003152T2 (ja)
DK (1) DK1143997T3 (ja)
EA (1) EA003927B1 (ja)
EE (1) EE05543B1 (ja)
ES (1) ES2200808T3 (ja)
HK (2) HK1043059B (ja)
HU (1) HU226149B1 (ja)
IL (2) IL144413A0 (ja)
NO (1) NO328814B1 (ja)
NZ (1) NZ512585A (ja)
PL (1) PL204713B1 (ja)
PT (1) PT1143997E (ja)
SI (1) SI1143997T1 (ja)
SK (1) SK287313B6 (ja)
TR (1) TR200102107T2 (ja)
UA (1) UA78483C2 (ja)
WO (1) WO2000043031A1 (ja)
ZA (1) ZA200105263B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA010180B1 (ru) * 2001-01-29 2008-06-30 Лаборатуар Сероно Са Применение ингибитора il-18 для приготовления лекарственного средства для лечения и/или профилактики кардиомиопатии
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1709965A3 (en) 2001-07-11 2006-12-27 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating cytokine mediate diseases
US7082134B1 (en) * 2002-01-18 2006-07-25 Juniper Networks, Inc. Redirect checking in a network device
US20070298041A1 (en) * 2002-06-28 2007-12-27 Tomlinson Ian M Ligands That Enhance Endogenous Compounds
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
DE60325275D1 (de) * 2003-02-07 2009-01-22 Austria Wirtschaftsservice Gmbh Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
CN102060806A (zh) 2003-09-11 2011-05-18 iTherX药品公司 细胞因子抑制剂
GB0327112D0 (en) 2003-11-21 2003-12-24 Clincial Designs Ltd Dispenser and reservoir
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
US20080014172A1 (en) * 2004-05-28 2008-01-17 Applied Research Systems Ars Holding N.V. Use of Il-17 in the Treatment of Fertility-Related Disorders
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
CN101282646B (zh) * 2005-07-12 2013-03-27 Dmi生物科学公司 治疗疾病的方法和产品
WO2008149147A2 (en) * 2007-06-06 2008-12-11 Domantis Limited Polypeptides, antibody variable domains and antagonists
AU2010264525B2 (en) * 2009-06-22 2015-04-02 Ampio Pharmaceuticals, Inc. Methods and products for treatment of diseases
PT2554174E (pt) * 2009-06-22 2015-12-15 Ampio Pharmaceuticals Inc Método para o tratamento de doenças
EA201500752A1 (ru) 2012-12-19 2016-05-31 Ампио Фармасьютикалс, Инк. Способ лечения заболеваний
WO2016140921A1 (en) 2015-03-02 2016-09-09 180 Therapeutics Lp Method of treating a localized fibrotic disorder using an il-33 antagonist

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037805A (en) * 1989-03-20 1991-08-06 The Salk Institute For Biological Studies Methods of contraception
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
EP1681305A3 (en) * 1991-03-18 2008-02-27 New York University Monoclonal and chimeric antibodies specific for human tumor necrosis factor
CA2123593C (en) * 1992-09-15 2000-03-14 Craig A. Smith Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
US5389657A (en) * 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
US5747532A (en) * 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
GB9607120D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
GB9616643D0 (en) * 1996-08-08 1996-09-25 Chiroscience Ltd Compounds
ATE429241T1 (de) * 1996-11-27 2009-05-15 Immunex Corp Verfahren zur regulierung der stickstoffmonoxid- erzeugung
US6514977B1 (en) * 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
BR0008182A (pt) 2001-11-06
SK287313B6 (sk) 2010-06-07
EP1143997B1 (en) 2003-06-04
EA003927B1 (ru) 2003-10-30
US20040057954A1 (en) 2004-03-25
KR20060128056A (ko) 2006-12-13
NO20013577D0 (no) 2001-07-19
CA2356737A1 (en) 2000-07-27
WO2000043031A1 (en) 2000-07-27
PL204713B1 (pl) 2010-02-26
JP2002535284A (ja) 2002-10-22
JP4601176B2 (ja) 2010-12-22
CN1698894A (zh) 2005-11-23
CN1212152C (zh) 2005-07-27
HK1082690A1 (en) 2006-06-16
HK1043059A1 (en) 2002-09-06
CZ302866B6 (cs) 2011-12-21
PL350002A1 (en) 2002-10-21
EP1022027A1 (en) 2000-07-26
IL144413A0 (en) 2002-05-23
CA2356737C (en) 2010-03-23
PT1143997E (pt) 2003-10-31
BG105691A (en) 2002-02-28
KR20010101397A (ko) 2001-11-14
NO20013577L (no) 2001-08-29
EE05543B1 (et) 2012-06-15
TR200102107T2 (tr) 2001-12-21
AR022251A1 (es) 2002-09-04
BG65556B1 (bg) 2008-12-30
ES2200808T3 (es) 2004-03-16
AU771964B2 (en) 2004-04-08
DE60003152T2 (de) 2004-03-25
EA200100799A1 (ru) 2001-12-24
ZA200105263B (en) 2002-06-26
HK1043059B (zh) 2005-11-18
DE60003152D1 (de) 2003-07-10
HU226149B1 (en) 2008-05-28
IL144413A (en) 2009-05-04
CZ20012656A3 (cs) 2002-02-13
CN1337883A (zh) 2002-02-27
CN100594932C (zh) 2010-03-24
EP1143997A1 (en) 2001-10-17
SK10292001A3 (sk) 2001-12-03
UA78483C2 (en) 2007-04-10
NO328814B1 (no) 2010-05-18
US6663865B1 (en) 2003-12-16
ATE242002T1 (de) 2003-06-15
KR100685106B1 (ko) 2007-02-22
EE200100378A (et) 2002-10-15
AU1997300A (en) 2000-08-07
NZ512585A (en) 2003-08-29
HUP0105103A3 (en) 2004-08-30
DK1143997T3 (da) 2003-09-15
HUP0105103A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
HK1082690A1 (en) Tumor necrosis factor antagonists and their use in endometriosis
HK1054225A1 (zh) Mch拮抗劑和它們在治療肥胖中的用途
IL157365A0 (en) Mch antagonists and their use in the treatment of obesity
IL155772A0 (en) Piperidine mch antagonists and their use in the treatment of obesity
IL154685A0 (en) 2-,3-,4-, or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy
IL144954A0 (en) Quinazolines and therapeutic use thereof
IL149496A0 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
HUP0203430A3 (en) Quinazolinones and their use
IL144508A0 (en) Compositions and methods for use in targeting vascular destruction
PL373484A1 (en) Vanilloid receptor ligands and their use in treatments
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
AU2003298794A8 (en) Recombinant immunotoxin and use in treating tumors
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU2003250831A8 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
HUP0202339A3 (en) Use of cortisol antagonists in the treatment of heat failure
GB9818018D0 (en) Microparticles and their use in therapy
GB0026428D0 (en) Hydroimidazolone derivatives and their use in therapy
HK1053266A1 (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
AU2002241547A1 (en) Mch antagonists and their use in the treatment of obesity
GB0015676D0 (en) Aryl compounds their preparation and their use in therapy
GB0130733D0 (en) Therapeutic compounds and their use in therapy
GB9905315D0 (en) Therapy and use of compounds in therapy
GB9905307D0 (en) Therapy and use of compounds in therapy